Aims In this study, we aimed to evaluate whether human amniotic mesenchymal stem cells
(AMMs) have angio-vasculogenic properties and to determine their therapeutic effects on …

Although human amniotic mesenchymal stem cells (AMMs) have been recognised as a
promising stem cell resource, their therapeutic potential for wound healing has not been …

The ability of stem cells to differentiate into multiple cell lineages has ushered in exciting
possibilities for stem cell based therapies that would be used to regenerate and repair …

Bone marrow (BM) multipotent mesenchymal stromal cells (MSCs) present with multipotent
differentiation potential and immunomodulatory properties. As an alternative to bone …

Human amniotic membranes and amniotic fluid have attracted increasing attention in recent
years as a possible reserve of stem cells that may be useful for clinical application in …

Although mesenchymal stem cells (MSCs) can be obtained from the fetal membrane (FM),
little information is available regarding biological differences in MSCs derived from different …

Background Amniotic membrane is a highly promising cell source for tissue engineering.
Being part of the placenta, this tissue is abundantly available. It can be processed easily to …

The mesenchymal stem cells (MSCs), which are derived from the mesoderm, are considered
as a readily available source for tissue engineering. They have multipotent differentiation …

Human perinatal tissue is an abundant source of mesenchymal stromal cells (MSCs) and
lacks the ethical concerns. Perinatal MSCs can be obtained from various tissues as like …

Abstract Background Mesenchymal stem cells (MSCs) have emerged as a promising
regenerative tool, owing mainly to their multi-differentiation potential and …